RxDoctor Payments Data

Paul Hunter

Obstetrics & Gynecology · Charleston, WVNPI 1487657631

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations.

$6,398in general payments, 2019–2025

Across 316 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$959
  • Pfizer$761
  • AbbVie$628
  • Astellas Pharma US Inc$554
  • Exeltis, USA Inc.$526
  • Sumitomo Pharma America, Inc.$316
  • plus $3K from 27 others

What the payments were for

  • Food & beverage$6,31499%
  • Education$831%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,398 in reported general payments places this provider in the 85th percentile of 172 obstetrics & gynecology providers in West Virginia.

See all obstetrics & gynecology providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron36$32,196
PremarinEstrogens, Conjugated16$7,067
Estradiol (Twice Weekly)Estradiol23$2,336
Ibandronate Sodium21$746
Estradiol19$507
Norethindrone Acetate14$93

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$554$32,19636 claims
PfizerPremarin$761$7,06716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 172 obstetrics & gynecology providers in West Virginia.

Other obstetrics & gynecology in Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →